tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Advertisement

Janux Therapeutics Inc (JANX) Stock Investors

Compare
499 Followers
Based on 830,143 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold JANX
On average, investors allocate 3.82% of their portfolios to JANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 830,143 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding JANX

0.5%
Last 7
Days
0.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding JANX, out of 830,143 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

JANX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.50%
$27.75
Opened
<0.01%
$23.46
Reduced
0.41%
$24.60
Opened
0.00%
$27.37
Reduced
4.18%
$31.53
Based on the activity of investors who made their portfolios public
The table shows changes in JANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

JANX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.72%
-0.38%
+0.59%
4.16B
Healthcare
Crispr Therapeutics AG
3.11%
+0.56%
+0.95%
5.08B
Healthcare
Zeta Global Holdings Corp
3.42%
+0.72%
+3.76%
4.39B
Technology
Cleanspark
4.13%
+3.60%
+4.04%
3.44B
Financial
Riot Platforms
4.28%
+2.53%
+4.69%
5.56B
Financial
Boston Scientific
2.65%
<+0.01%
+7.17%
149.67B
Healthcare
Recursion Pharmaceuticals
3.04%
-0.14%
-2.54%
2.30B
Healthcare
Bitfarms
3.72%
+0.15%
+1.20%
1.94B
Financial
Zscaler
3.06%
+2.75%
+2.26%
40.18B
Technology
UiPath
2.81%
+1.15%
+0.53%
7.22B
Technology
Based on the activity of 830,143 active portfolios
Open your Smart Portfolio

JANX Investor Analysis

JANX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
2.9%
of JANX holders
are under 35
Average Segment Performance
Average P/E Ratio37.77
Beta-3.56
Dividend Yield5.01%
JANX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.0%
of JANX holders
are between 35–55
Average Segment Performance
Average P/E Ratio34.48
Beta5.28
Dividend Yield5.07%
JANX investors over 55

Over 55

7.1%
Last 30 days
Holdings Change
57.1%
of JANX holders
are over 55
Average Segment Performance
Average P/E Ratio32.80
Beta0.79
Dividend Yield3.92%
Overview of age group and performance of JANX stock investors
See who invests in JANX according to age group and performance.

FAQ

How many retail Investors hold JANX?
<0.1% of TipRanks' retail investors hold JANX in their portfolios.
    What is JANX Investor Sentiment?
    JANX’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of JANX in the last 7 days?
      ▲ 0.5% of TipRanks' retail investors changed their holding of JANX in the last 7 days.
        What percentage of retail investors changed their holding of JANX in the last 30 days?
        ▲ 0.8% of TipRanks' retail investors changed their holding of JANX in the last 30 days.
          What is the average age of retail investors who hold JANX?
          The average age of JANX Holders is over 55.
            What other stocks have JANX investors also bought?
            JANX Investors also bought VKTX, CRSP, ZETA, CLSK, RIOT, BSX, RXRX, BITF, ZS, PATH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis